Larimar Therapeutics OverviewLarimar Therapeutics Other Income Expense Net
Other Income/Expense Net for LRMR.
Quarterly Other Income/Expense
$1.50M
↓ 21.13% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$6.42M
↓ 36.51% YoY
Trailing 12 months ending Mar 31, 2026